BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2016
View Archived Issues
USP11 shows promise as a therapeutic target in breast cancer
Read More
Angle initiates European ovarian cancer study
Read More
Iron Horse Diagnostics and Euroimmun enter license agreement to launch first ALS biologic diagnostic
Read More
AstraZeneca receives European approval for Qtern
Read More
FDA grants orphan drug designation to combination of antibodies against Ebola
Read More
FORMA Therapeutics reports ubiquitin hydrolase inhibitors
Read More
Novira Therapeutics reveals antiviral compounds to treat hepatitis B
Read More
Merck KGaA initiates phase II trial in children with schistosomiasis
Read More
Eurpean Commission grants orphan drug designation to Alcobra's metadoxine
Read More
FDA advisory committee votes to recommend brodalumab for moderate to severe plaque psoriasis
Read More
Research identifies PARG as a potential target for breast cancer
Read More
Johnson & Johnson reflects on accomplishments of second quarter 2016
Read More
Synaffix platform technologies generate ADCs with improved therapeutic index
Read More
Genetic variation in a lincRNA gene is associated with pneumococcal bacteremia
Read More
Aeglea updates progress of AEB-1102 clinical program
Read More
Scientists discover novel ROMK inhibitor SHR-1977 for treating hypertension
Read More
Topline results from Arbutus' phase I/II study of TKM-PLK1 in HCC
Read More
Jounce Therapeutics and Celgene establish immuno-oncology collaboration
Read More
ProQR Therapeutics announces fast track designation from the FDA for QR-010
Read More
BladderPredict diagnostic tool launched for bladder cancer
Read More
Cynapsus Therapeutics reaches agreement with the EMA for APL-130277 development
Read More
FDA grants fast track designation to CRLX-101
Read More
Immune Pharmaceuticals enters agreement with NPT for AmiKet
Read More
Eisai and Arena Pharmaceuticals obtain NDA approval for Belviq XR
Read More
First-in-human trial begins for GLS-5700 vaccine against Zika virus
Read More